ID3 MEDICAL: what changed
ID3 MEDICAL
Largest movements
- Receivables within one year +€131,733
up €131,733 (+66.2%), from €198,972 to €330,705
of which Trade receivables: +€196,091
- Cash +€55,846
up €55,846 (+189%), from €29,542 to €85,388
mainly Net result for the year (+€233,425) and Other debts (+€100,000)
- Reserves +€241,659
up €241,659 (+9,666%), from €2,500 to €244,159
of which Distributable reserves: +€241,659
- Profit (loss) carried forward -€108,234
down €108,234 (-100%), from €108,234 to €0
- Other debts +€100,000
up €100,000 (+9,662%), from €1,035 to €101,035
- Trade debts -€63,890
down €63,890 (-71.2%), from €89,746 to €25,856
- Tax, wage and social debts +€16,648
up €16,648 (+170%), from €9,792 to €26,440
of which Taxes: +€15,590
- Gross operating margin +€229,017
up €229,017 (+122%), from €187,247 to €416,264
- Taxes +€61,976
new in 2025: €61,976
- Staff costs -€59,273
down €59,273 (-33.2%), from €178,477 to €119,204
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €236,307 | €422,491 | +€186,184 | +78.8% |
| Fixed assets | 21/28 | €2,797 | €1,177 | -€1,620 | -57.9% |
| Intangible fixed assets | 21 | €1,646 | €240 | -€1,406 | -85.4% |
| Tangible fixed assets | 22/27 | €693 | €479 | -€214 | -30.9% |
| Furniture and vehicles | 24 | €693 | €479 | -€214 | -30.9% |
| Financial fixed assets | 28 | €458 | €458 | = | 0.0% |
| Current assets | 29/58 | €233,510 | €421,314 | +€187,804 | +80.4% |
| Amounts receivable within one year | 40/41 | €198,972 | €330,705 | +€131,733 | +66.2% |
| Trade receivables | 40 | €122,233 | €318,324 | +€196,091 | +160% |
| Other amounts receivable | 41 | €76,739 | €12,381 | -€64,358 | -83.9% |
| Cash at bank and in hand | 54/58 | €29,542 | €85,388 | +€55,846 | +189% |
| Deferred charges and accrued income | 490/1 | €4,996 | €5,221 | +€225 | +4.5% |
| Total equity and liabilities | 10/49 | €236,307 | €422,491 | +€186,184 | +78.8% |
| Equity | 10/15 | €135,734 | €269,159 | +€133,425 | +98.3% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Reserves | 13 | €2,500 | €244,159 | +€241,659 | +9,666% |
| Non-distributable reserves | 130/1 | €2,500 | €2,500 | = | 0.0% |
| Reserves not available under the articles | 1311 | €2,500 | €2,500 | = | 0.0% |
| Distributable reserves | 133 | - | €241,659 | +€241,659 | |
| Profit (loss) carried forward | 14 | €108,234 | €0 | -€108,234 | -100% |
| Amounts payable | 17/49 | €100,573 | €153,331 | +€52,759 | +52.5% |
| Amounts payable within one year | 42/48 | €100,573 | €153,331 | +€52,759 | +52.5% |
| Current portion of amounts payable after more than one year | 42 | €0 | - | = | |
| Financial debts | 43 | €0 | €0 | = | |
| Credit institutions | 430/8 | €0 | €0 | = | |
| Trade debts | 44 | €89,746 | €25,856 | -€63,890 | -71.2% |
| Suppliers | 440/4 | €89,746 | €25,856 | -€63,890 | -71.2% |
| Taxes, remuneration and social security | 45 | €9,792 | €26,440 | +€16,648 | +170% |
| Taxes | 450/3 | - | €15,590 | +€15,590 | |
| Remuneration and social security | 454/9 | €9,792 | €10,851 | +€1,059 | +10.8% |
| Other amounts payable | 47/48 | €1,035 | €101,035 | +€100,000 | +9,662% |
| Non-recurring operating income | 76A | €525 | €0 | -€525 | -100% |
| Remuneration, social security and pensions | 62 | €178,477 | €119,204 | -€59,273 | -33.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,706 | €1,620 | -€86 | -5.0% |
| Other operating charges | 640/8 | €411 | €475 | +€64 | +15.5% |
| Gross operating margin | 9900 | €187,247 | €416,264 | +€229,017 | +122% |
| Operating profit (loss) | 9901 | €6,653 | €294,966 | +€288,312 | +4,333% |
| Financial income | 75/76B | €43 | €1,001 | +€958 | +2,252% |
| Recurring financial income | 75 | €43 | €1,001 | +€958 | +2,252% |
| Financial charges | 65/66B | €791 | €566 | -€225 | -28.4% |
| Recurring financial charges | 65 | €791 | €566 | -€225 | -28.4% |
| Profit (loss) for the period before taxes | 9903 | €5,905 | €295,401 | +€289,495 | +4,902% |
| Income taxes | 67/77 | - | €61,976 | +€61,976 | |
| Profit (loss) for the period | 9904 | €5,905 | €233,425 | +€227,520 | +3,853% |
| Profit (loss) for the period to be appropriated | 9905 | €5,905 | €233,425 | +€227,520 | +3,853% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.